Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Short term Debt (2016 - 2025)

Historic Short term Debt for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $103.0 million.

  • Surgery Partners' Short term Debt rose 585.82% to $103.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.0 million, marking a year-over-year increase of 585.82%. This contributed to the annual value of $101.4 million for FY2024, which is 3833.56% up from last year.
  • Latest data reveals that Surgery Partners reported Short term Debt of $103.0 million as of Q3 2025, which was up 585.82% from $110.0 million recorded in Q2 2025.
  • Surgery Partners' Short term Debt's 5-year high stood at $116.9 million during Q3 2022, with a 5-year trough of $60.4 million in Q4 2021.
  • For the 5-year period, Surgery Partners' Short term Debt averaged around $79.8 million, with its median value being $69.6 million (2021).
  • Its Short term Debt has fluctuated over the past 5 years, first skyrocketed by 9226.97% in 2022, then crashed by 4687.77% in 2023.
  • Over the past 5 years, Surgery Partners' Short term Debt (Quarter) stood at $60.4 million in 2021, then grew by 3.97% to $62.8 million in 2022, then increased by 16.72% to $73.3 million in 2023, then surged by 38.34% to $101.4 million in 2024, then grew by 1.58% to $103.0 million in 2025.
  • Its last three reported values are $103.0 million in Q3 2025, $110.0 million for Q2 2025, and $103.9 million during Q1 2025.